HHS Allows Six Unapproved Peptides for Pharmacy Compounding
Federal health officials have temporarily expanded access to six experimental peptides by allowing eligible compounding pharmacies and other licensed providers to manufacture them…
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 28 12:56 ETSource: Cirebon Times
From the source
Read at cirebontimes.comHHS Allows Six Unapproved Peptides for Pharmacy Compounding
Federal health officials have temporarily expanded access to six experimental peptides by allowing eligible compounding pharmacies and other licensed providers to manufacture them without immediate federal enforcement action. The Department of Health and Human Services announced the policy on Wednesday, October 28, 2026, while the Food and Drug Administration continues evaluating whether these sub
